NetworkNewsBreaks – CytoDyn Inc. (CYDY) Interim CMO to Present at 11th Annual Conference on Stem Cell and Regenerative Medicine

CytoDyn Inc. (OTCQB: CYDY), a biotechnology company developing innovative treatments for multiple therapeutic indications, this morning announced that Richard G. Pestell, M.D., Ph.D., president of the Pennsylvania Cancer and Regenerative Medicine Research Center, distinguished professor at the Baruch S. Blumberg Institute and interim chief medical officer of CytoDyn, will deliver the keynote plenary speech at the 11th Annual Conference on Stem Cell and Regenerative Medicine in Helsinki, Finland. Pestell’s presentation, titled ‘Cancer stem cells, genetic drivers and therapeutic targeting via CCR5’, is scheduled to take place on Monday, October 15, from 10-11 am EEST. Pestell will present recent scientific evidence demonstrating the effectiveness of PRO 140 (leronlimab), which is shown to bind to CCR5 in human breast cancer, block CCR5 signaling induced by cytokines and block human breast cancer cell invasion.

To view the full press release, visit http://nnw.fm/SgzM0

About CytoDyn

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells.  The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The Company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first quarter of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with PRO 140 as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of PRO 140 monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that PRO 140 monotherapy can prevent viral escape in HIV-infected patients, with some patients on PRO 140 monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate PRO 140 for the prevention of GvHD and expects to initiate clinical trials with PRO 140 in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com

More from NetworkNewsBreaks

NetworkNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Adds Taxation Reporting Technology to its Proprietary Compliance Platform NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Announces Results of Independent Studies Supporting Restart of Canadian Refinery NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Ships Initial Purchase Order from the NSLC

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.

More News From Enter Hollywood

Prince Harry in another catch-up with war widow in Sydney

Oct 16, 2018

SYDNEY — There's clearly a special bond between Prince Harry and a 98-year-old war widow who gave him a warm hug Tuesday when they met — again — in Sydney. It's a regular catch-up. The widow, Daphne Dunne, tries to cross the prince's path whenever he comes to Australia. It's a natural fit for Harry, who has made championing the cause of veterans one of his principal causes. He first noted Dunne when he visited Sydney in 2015 and saw that she was wearing a Victoria Cross. That's a significant award that wouldn't escape Harry's eye. It is awarded to...

AP PHOTOS: Royal couple in Australia as pregnancy announced

Oct 16, 2018

SYDNEY — The Duke and Duchess of Sussex are on a 16-day visit to Australia, Fiji, Tonga and New Zealand that began in Sydney with the surprise announcement that the royal couple are expecting their first child. News that the former Meghan Markle is pregnant has made front-page headlines across Australia. Meghan's tight-fitting dress barely revealed a bump as she and Prince Harry were welcomed at their first event Tuesday at the Sydney harbor-side mansion where the two are staying. The couple later traveled by boat to Taronga Park Zoo, where they opened a research center and met two 10-month-old...

Prince Harry and Meghan start Aussie tour with baby gifts

Oct 16, 2018

SYDNEY — A beaming Duke and Duchess of Sussex thrilled thousands of fans outside the Sydney Opera House on Tuesday during their first meeting with the general public since the former Meghan Markle's newly announced pregnancy. Prince Harry and Meghan spent longer than the 20 minutes allocated in their schedule to speak to and shake hands with as many well-wishers as possible. Meghan, wearing a beige trench coat over a sleeveless cream dress by Australian designer Karen Gee, accepted cards and flowers from an enthusiastic crowd. The news of the pregnancy was announced after the couple arrived in Sydney on...

The Latest: Tourists in London react to royal baby news

Oct 16, 2018

SYDNEY — The Latest on Prince Harry and his wife, the Duchess of Sussex, who are expecting a child in the spring (all times local): 10:45 p.m. International visitors to Buckingham Palace to see the popular Changing of the Guard ceremony have reacted with joy to the news that Prince Harry and Meghan, Duchess of Sussex, are expecting their first child. A 29-year-old Canadian tourist Braden Fraser from Toronto said that "it's wonderful." Fraser said "I was happy about the first couple of marriages and the children coming. I'm glad to see the monarchy is carrying on. Back home we...

And baby makes three: Prince Harry and Meghan's child on way

Oct 16, 2018

CANBERRA, Australia — They both wanted children. They knew it was time. Meghan had ended her acting career and moved to Britain to be a full-time royal. Prince Harry had stepped down from the military and wanted to settle down. Their marriage was a five-star glamour blowout: the spectacular Windsor Castle setting, the horse-drawn carriage on a warm spring day, the vintage Jaguar with the top down, the Hollywood A-listers mixing with real-life royalty. And now comes the very welcome word that Harry and Meghan, the duchess of Sussex, are expecting their first child in the spring. It is the...

Sign up now!